Member Info for Wiggly

Its coming!

Livedataa, where did you read GAD have 120m daily capacity?

When we look back on the past 2 weeks, we will all see it for what is was, an orchestrated daylight robbery, stealing shares from the underinformed and over leveraged.

Those articles, the new posters etc, all designed to spread fear and pocket cheap shares.

There is a very very high probability that the news to come (I think it could be today/tomorrow) will be exceptional and everyone knows this.

This will close at last weeks highs. Serious fomo kicking in towards end of day

Does the market smell an intra day coming?

?

She is about to blow !

The long term holders know it.

The potential is staggering and is widely known by the market.

Expect dirty tricks in order to 'steal' your shares.

There is much more to the collab between Bruker/Adeptrix/AVCT than just the Covid assay.

Throw us a bone, please...

It really is that simple and the probability of it being A is very very high!

Are happy to take very large volumes at market price. They are playing a blinder here, soaking all the sells up. When news lands, they will NT all the way to 300+ (possibly much higher) and will make a huge profit!

I hope AS catches them all with a massive intra day announcement!

Really really strange that Mologic would not only offer their capacity to AVCT (by the way, GAD are ready to stat manufacturing the AVCT test right now........e.g. in time to support a product launch during Q1....) but also support a direct competitor to accelerate their route to market by supporting with the CE marking, TO ENSURE WE ARE READY TO ROLL BY Q1.

I think that Mologic, having reviewed closely the performance data associated with the AVCT test (they are specialists in this field) will know just how good the test is, hence reason they conceded their position and pivoted to support AVCT with CE marking and capacity.

See Mologic RNS from Feb 8th;

The partnership will provide a faster route to market for Avacta's rapid antigen test by CE marking it for professional use under Mologic's existing ISO13485 quality system. The CE mark will then be transferred to Avacta when it receives ISO13485 accreditation, which is expected by the end of March 2021.

You do all know that the initial CV data (56 samples) that delivered 96.7/100 was sufficient to CE mark and has likely been used by Mologic to CE mark, in line with what was stated in the Feb 8th RNS?

He is expected to discuss the role of testing to facilitate the easing of lock down. Not sure he will discuss the sovereign test though... If he does, then I guess there could be an update from AVCT to coincide.

I don't think the RNS needs to coincide with any GOV announcement. The RNS we await will detail the S&S CV, and perhaps also the CE confirmation. This type of detail does not hinge on any government announcement.

Is the bounce on? Looks as though it could be

With the news we all expect and it will be NT all the way to 300+.

I think it is blindingly obvious what is happening here. A significant number of traders leveraged up in anticipation of transformational news 'around the end of Q1' and are now being squeezed out by the market (perhaps deliberately).

These 'weak' positions are being sold into sticky hands, so when the news does land - AND IT WILL - there wont be any many shares to buy.

I am 100% confident that transformational news is coming and agree with earlier posts, if any doubt from AS, he would not be proceeding down this final path, which is to showcase the power of the Affimers on the global stage.